title: Free-radical degradation of high-molar-mass hyaluronan induced by ascorbate plus cupric ions: evaluation of antioxidative effect of cysteine-derived compounds.
abstract: Based on our previous findings, the present study has focused on free-radical-mediated degradation of the synovial biopolymer hyaluronan. The degradation was induced in vitro by the Weissberger's system comprising ascorbate plus cupric ions in the presence of oxygen, representing a model of the early phase of acute synovial joint inflammation. The study presents a novel strategy for hyaluronan protection against oxidative degradation with the use of cysteine-derived compounds. In particular, the work objectives were to evaluate potential protective effects of reduced form of L-glutathione, L-cysteine, N-acetyl-L-cysteine, and cysteamine, against free-oxygen-radical-mediated degradation of high-molar-mass hyaluronan in vitro. The hyaluronan degradation was influenced by variable activity of the tested thiol compounds, also in dependence of their concentration applied. It was found that L-glutathione exhibited the most significant protective and chain-breaking antioxidative effect against the hyaluronan degradation. Thiol antioxidative activity, in general, can be influenced by many factors such as various molecule geometry, type of functional groups, radical attack accessibility, redox potential, thiol concentration and pK(a), pH, ionic strength of solution, as well as different ability to interact with transition metals. Antioxidative activity was found to decrease in the following order: L-glutathione, cysteamine, N-acetyl-L-cysteine, and L-cysteine. These findings might be beneficial in future development of potential drugs in the treatment of synovial hyaluronan depletion-derived diseases.
authors.affiliation: Department of Carbohydrate Enzymology, Institute of Chemistry, Slovak Academy of Sciences, SK-84538 Bratislava. eva.hrabarova@savba.sk
authors.forename: Eva
authors.initials: E
authors.lastname: Hrabárová
authors.forename: Katarína
authors.initials: K
authors.lastname: Valachová
authors.forename: Ivo
authors.initials: I
authors.lastname: Juránek
authors.forename: Ladislav
authors.initials: L
authors.lastname: Soltés
mesh_terms: D000276:Adjuvants, Immunologic / Q000378:metabolism; D000975:Antioxidants / Q000494:pharmacology*; D001205:Ascorbic Acid / Q000494:pharmacology*; D003300:Copper / Q000494:pharmacology*; D003543:Cysteamine / Q000494:pharmacology; D003545:Cysteine / Q000494:pharmacology; D005609:Free Radicals / Q000378:metabolism*; D006820:Hyaluronic Acid / Q000378:metabolism*; D010084:Oxidation-Reduction; D010100:Oxygen / Q000378:metabolism; D013438:Sulfhydryl Compounds / Q000494:pharmacology*
chemical_list: D000276:Adjuvants, Immunologic; D000975:Antioxidants; D005609:Free Radicals; D013438:Sulfhydryl Compounds; D003543:Cysteamine; D003300:Copper; D006820:Hyaluronic Acid; D003545:Cysteine; D001205:Ascorbic Acid; C029892:cupric chloride; D010100:Oxygen